Sentiment-Signal
12,8
Stark Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)
Score-Verlauf (90 Tage)
Kritische 8-K Meldungen
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 15.09.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | (a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of |
Stammdaten
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy dataset of advanced cancer patients. It is also developing LUNAR-2 test for the early detection of colorectal cancer in asymptomatic individuals eligible; and GuardantConnect, an integrated software-based solution for clinical and biopharmaceutical customers seeking to connect patients tested with the Guardant360 assay with actionable alterations with potentially relevant clinical trials. In addition, the company offers Guardant Reveal Test for neoadjuvant and adjuvant treatment selection in early-stage cancer patients; Guardant360 tissue genotyping product; and Guardant-19 for use in the detection of the novel coronavirus. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, and kits fulfillment related services to biopharmaceutical companies and medical institutions. The company was incorporated in 2011 and is headquartered in Redwood City, California.
Unternehmen & Branche
| Name | Guardant Health, Inc. |
|---|---|
| Ticker | GH |
| CIK | 0001576280 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Diagnostics & Research |
| SIC | 8071 · Services-Medical Laboratories |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 10,83 Mrd. USD |
| Beta | 1,65 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 982,021,000 | -416,277,000 | -3.32 | 2,013,659,000 | -99,307,000 |
| 2025-09-30 | 10-Q | 265,196,000 | -92,725,000 | -0.74 | 1,276,786,000 | -354,473,000 |
| 2025-06-30 | 10-Q | 232,088,000 | -99,899,000 | -0.80 | 1,331,999,000 | -305,475,000 |
| 2025-03-31 | 10-Q | 203,471,000 | -95,159,000 | -0.77 | 1,344,226,000 | -250,789,000 |
| 2024-12-31 | 10-K | 739,016,000 | -436,373,000 | -3.56 | 1,485,609,000 | -139,647,000 |
| 2024-09-30 | 10-Q | 191,476,000 | -107,754,000 | -0.88 | 1,538,727,000 | -60,096,000 |
| 2024-06-30 | 10-Q | 177,235,000 | -102,628,000 | -0.84 | 1,609,340,000 | -1,613,000 |
| 2024-03-31 | 10-Q | 168,491,000 | -114,985,000 | -0.94 | 1,704,598,000 | 68,285,000 |
| 2023-12-31 | 10-K | 563,948,000 | -479,449,000 | -4.28 | 1,786,421,000 | 158,684,000 |
| 2023-09-30 | 10-Q | 143,030,000 | -86,102,000 | -0.73 | 1,797,231,000 | 228,299,000 |
| 2023-06-30 | 10-Q | 137,150,000 | -72,771,000 | -0.67 | 1,840,017,000 | 292,726,000 |
| 2023-03-31 | 10-Q | 128,714,000 | -133,533,000 | -1.30 | 1,511,631,000 | -44,551,000 |
| 2022-12-31 | 10-K | 449,538,000 | -654,588,000 | -6.41 | 1,609,985,000 | 60,180,000 |
| 2022-09-30 | 10-Q | 117,404,000 | -161,994,000 | -1.58 | 1,701,779,000 | 166,745,000 |
| 2022-06-30 | 10-Q | 109,144,000 | -229,432,000 | -2.25 | 1,853,737,000 | 319,087,000 |
| 2022-03-31 | 10-Q | 96,099,000 | -123,228,000 | -1.21 | 2,129,598,000 | 533,040,000 |
| 2021-12-31 | 10-K | 373,653,000 | -384,770,000 | -4.00 | 2,204,499,000 | 645,005,000 |
| 2021-09-30 | 10-Q | 94,779,000 | -1.06 | 2,225,534,000 | 709,420,000 | |
| 2021-06-30 | 10-Q | 92,101,000 | -0.96 | 2,291,885,000 | 788,065,000 | |
| 2021-03-31 | 10-Q | 78,665,000 | -1.09 | 2,346,741,000 | 847,046,000 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-04-16 | Tariq Musa | Director | Open Market Sale | -116 | 84.83 | -9,840.28 | -1,1% | |
| 2026-04-06 | Monroe Terilyn J. | Officer, Chief People Officer | Open Market Sale | -3,832 | 92.68 | -355,149.76 | -41,5% | |
| 2026-03-18 | Tariq Musa | Director | Open Market Sale | -348 | 88.09 | -30,655.32 | -3,6% | |
| 2026-03-16 | Bell Michael Brian | Officer, Chief Financial Officer | Open Market Sale | -3,000 | 87.04 | -261,111.00 | -30,5% | |
| 2026-03-06 | Hidalgo Medina Manuel | Director | Open Market Sale | -300 | 91.30 | -27,390.03 | -3,2% | |
| 2026-03-06 | Hidalgo Medina Manuel | Director | Open Market Sale | -1,000 | 91.61 | -91,606.50 | -10,7% | |
| 2026-03-04 | Kalia Kumud | Officer, Chief Information Officer | Open Market Sale | -26,980 | 95.12 | -2,566,310.62 | -299,6% | |
| 2026-03-04 | Kalia Kumud | Officer, Chief Information Officer | Open Market Sale | -13,020 | 95.73 | -1,246,349.92 | -145,5% | |
| 2026-01-21 | Monroe Terilyn J. | Officer, Chief People Officer | Open Market Sale | -3,249 | 115.70 | -375,902.15 | -43,9% | |
| 2026-01-21 | Monroe Terilyn J. | Officer, Chief People Officer | Open Market Sale | -3,619 | 113.48 | -410,681.59 | -47,9% | |
| 2026-01-21 | Monroe Terilyn J. | Officer, Chief People Officer | Open Market Sale | -1,703 | 112.34 | -191,318.09 | -22,3% | |
| 2026-01-07 | Monroe Terilyn J. | Officer, Chief People Officer | Open Market Sale | -88 | 113.44 | -9,982.69 | -1,2% | |
| 2026-01-07 | Monroe Terilyn J. | Officer, Chief People Officer | Open Market Sale | -6,311 | 111.75 | -705,267.50 | -82,3% | |
| 2026-01-07 | Monroe Terilyn J. | Officer, Chief People Officer | Open Market Sale | -3,632 | 112.62 | -409,029.30 | -47,8% | |
| 2025-12-17 | Tariq Musa | Director | Open Market Sale | -116 | 101.46 | -11,769.36 | -1,4% | |
| 2025-12-15 | Eltoukhy Helmy | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -6,620 | 104.02 | -688,628.29 | -80,4% | |
| 2025-12-15 | Eltoukhy Helmy | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -83,945 | 103.80 | -8,713,591.73 | -1017,3% | |
| 2025-12-15 | Chudova Darya | Officer, Chief Technology Officer | Open Market Sale | -5,451 | 104.04 | -567,131.85 | -66,2% | |
| 2025-12-08 | Chudova Darya | Officer, Chief Technology Officer | Open Market Sale | -13,664 | 105.04 | -1,435,226.93 | -167,6% | |
| 2025-12-08 | Talasaz AmirAli | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -30,760 | 105.34 | -3,240,172.27 | -378,3% | |
| 2025-12-08 | Talasaz AmirAli | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -15,000 | 104.21 | -1,563,124.50 | -182,5% | |
| 2025-12-08 | Talasaz AmirAli | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -4,240 | 106.00 | -449,440.00 | -52,5% | |
| 2025-12-08 | Hidalgo Medina Manuel | Director | Open Market Sale | -1,000 | 105.00 | -105,000.00 | -12,3% | |
| 2025-12-08 | Hidalgo Medina Manuel | Director | Open Market Sale | -250 | 105.00 | -26,250.00 | -3,1% | |
| 2025-12-08 | Kalia Kumud | Officer, Chief Information Officer | Open Market Sale | -2,000 | 104.60 | -209,204.20 | -24,4% | |
| 2025-12-08 | Chudova Darya | Officer, Chief Technology Officer | Open Market Sale | -9,271 | 106.00 | -982,752.89 | -114,7% | |
| 2025-12-05 | Freeman Chris | Officer, Chief Commercial Officer | Open Market Sale | -478 | 101.43 | -48,482.44 | -5,7% | |
| 2025-12-05 | Bell Michael Brian | Officer, Chief Financial Officer | Open Market Sale | -250 | 105.82 | -26,454.00 | -3,1% | |
| 2025-12-05 | Bell Michael Brian | Officer, Chief Financial Officer | Open Market Sale | -1,190 | 107.26 | -127,642.38 | -14,9% | |
| 2025-12-05 | Bell Michael Brian | Officer, Chief Financial Officer | Open Market Sale | -2,533 | 103.24 | -261,509.20 | -30,5% | |
| 2025-12-05 | Bell Michael Brian | Officer, Chief Financial Officer | Open Market Sale | -3,267 | 101.46 | -331,482.89 | -38,7% | |
| 2025-12-05 | Bell Michael Brian | Officer, Chief Financial Officer | Open Market Sale | -3,284 | 106.70 | -350,408.38 | -40,9% | |
| 2025-12-05 | Bell Michael Brian | Officer, Chief Financial Officer | Open Market Sale | -5,027 | 103.96 | -522,611.44 | -61,0% | |
| 2025-12-05 | Bell Michael Brian | Officer, Chief Financial Officer | Open Market Sale | -5,568 | 106.68 | -594,018.18 | -69,4% | |
| 2025-12-05 | Bell Michael Brian | Officer, Chief Financial Officer | Open Market Sale | -7,567 | 103.26 | -781,394.15 | -91,2% | |
| 2025-12-05 | Bell Michael Brian | Officer, Chief Financial Officer | Open Market Sale | -8,033 | 101.42 | -814,735.78 | -95,1% | |
| 2025-12-05 | Bell Michael Brian | Officer, Chief Financial Officer | Open Market Sale | -8,774 | 102.11 | -895,931.57 | -104,6% | |
| 2025-12-05 | Bell Michael Brian | Officer, Chief Financial Officer | Open Market Sale | -11,978 | 103.96 | -1,245,252.04 | -145,4% | |
| 2025-12-05 | Bell Michael Brian | Officer, Chief Financial Officer | Open Market Sale | -22,891 | 102.11 | -2,337,301.58 | -272,9% | |
| 2025-12-05 | Freeman Chris | Officer, Chief Commercial Officer | Open Market Sale | -228 | 106.63 | -24,312.14 | -2,8% | |
| 2025-12-05 | Freeman Chris | Officer, Chief Commercial Officer | Open Market Sale | -244 | 104.10 | -25,400.03 | -3,0% | |
| 2025-12-05 | Freeman Chris | Officer, Chief Commercial Officer | Open Market Sale | -372 | 103.48 | -38,495.12 | -4,5% | |
| 2025-12-05 | Freeman Chris | Officer, Chief Commercial Officer | Open Market Sale | -400 | 105.99 | -42,394.52 | -4,9% | |
| 2025-12-05 | Freeman Chris | Officer, Chief Commercial Officer | Open Market Sale | -744 | 102.31 | -76,115.66 | -8,9% | |
| 2025-12-05 | Freeman Chris | Officer, Chief Commercial Officer | Open Market Sale | -2,964 | 106.71 | -316,282.81 | -36,9% | |
| 2025-12-05 | Freeman Chris | Officer, Chief Commercial Officer | Open Market Sale | -3,414 | 103.25 | -352,505.06 | -41,2% | |
| 2025-12-05 | Freeman Chris | Officer, Chief Commercial Officer | Open Market Sale | -4,084 | 101.40 | -414,128.63 | -48,4% | |
| 2025-12-05 | Freeman Chris | Officer, Chief Commercial Officer | Open Market Sale | -6,555 | 103.97 | -681,534.49 | -79,6% | |
| 2025-12-05 | Freeman Chris | Officer, Chief Commercial Officer | Open Market Sale | -11,969 | 102.09 | -1,221,970.27 | -142,7% | |
| 2025-12-05 | CLARK IAN T | Director | Open Market Sale | -3,400 | 108.05 | -367,354.36 | -42,9% | |
| 2025-12-05 | CLARK IAN T | Director | Open Market Sale | -8,156 | 106.67 | -869,967.90 | -101,6% | |
| 2025-12-05 | CLARK IAN T | Director | Open Market Sale | -17,055 | 107.27 | -1,829,494.97 | -213,6% | |
| 2025-12-01 | Monroe Terilyn J. | Officer, Chief People Officer | Open Market Sale | -1,923 | 105.33 | -202,549.59 | -23,6% | |
| 2025-12-01 | Monroe Terilyn J. | Officer, Chief People Officer | Open Market Sale | -664 | 107.85 | -71,612.40 | -8,4% | |
| 2025-12-01 | Monroe Terilyn J. | Officer, Chief People Officer | Open Market Sale | -800 | 107.03 | -85,624.00 | -10,0% | |
| 2025-12-01 | Monroe Terilyn J. | Officer, Chief People Officer | Open Market Sale | -23,974 | 106.15 | -2,544,840.10 | -297,1% | |
| 2025-12-01 | Monroe Terilyn J. | Officer, Chief People Officer | Open Market Sale | -18,576 | 105.33 | -1,956,610.08 | -228,4% | |
| 2025-12-01 | Monroe Terilyn J. | Officer, Chief People Officer | Open Market Sale | -6,786 | 106.90 | -725,423.40 | -84,7% | |
| 2025-12-01 | Monroe Terilyn J. | Officer, Chief People Officer | Open Market Sale | -2,444 | 106.18 | -259,503.92 | -30,3% | |
| 2025-11-19 | Tariq Musa | Director | Open Market Sale | -116 | 96.25 | -11,165.00 | -1,3% | |
| 2025-11-07 | Hidalgo Medina Manuel | Director | Open Market Sale | -1,000 | 95.17 | -95,165.10 | -11,1% | |
| 2025-11-07 | Hidalgo Medina Manuel | Director | Open Market Sale | -500 | 95.23 | -47,615.05 | -5,6% | |
| 2025-11-07 | Saia John G. | Officer, Chief Legal Officer | Open Market Sale | -8,996 | 96.25 | -865,865.00 | -101,1% | |
| 2025-10-17 | Tariq Musa | Director | Open Market Sale | -116 | 66.95 | -7,766.20 | -0,9% | |
| 2025-10-17 | POTTER MYRTLE S | Director | Open Market Sale | -26 | 66.95 | -1,740.70 | -0,2% | |
| 2025-09-17 | POTTER MYRTLE S | Director | Open Market Sale | -26 | 55.63 | -1,446.38 | -0,2% | |
| 2025-09-17 | Tariq Musa | Director | Open Market Sale | -116 | 55.63 | -6,453.08 | -0,8% | |
| 2025-09-12 | Hidalgo Medina Manuel | Director | Open Market Sale | -2,165 | 54.16 | -117,250.77 | -13,7% | |
| 2025-09-09 | Eltoukhy Helmy | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -5,277 | 59.93 | -316,274.88 | -36,9% | |
| 2025-09-09 | Eltoukhy Helmy | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -294,723 | 59.44 | -17,519,720.32 | -2045,4% | |
| 2025-09-02 | Joyce Meghan V. | Director | Open Market Sale | -100 | 65.84 | -6,584.00 | -0,8% | |
| 2025-08-21 | Kalia Kumud | Officer, Chief Information Officer | Open Market Sale | -2,000 | 61.76 | -123,510.00 | -14,4% | |
| 2025-08-19 | Tariq Musa | Director | Open Market Sale | -116 | 59.02 | -6,846.32 | -0,8% | |
| 2025-08-19 | POTTER MYRTLE S | Director | Open Market Sale | -26 | 59.02 | -1,534.52 | -0,2% | |
| 2025-07-17 | Tariq Musa | Director | Open Market Sale | -116 | 48.20 | -5,591.20 | -0,7% | |
| 2025-07-17 | POTTER MYRTLE S | Director | Open Market Sale | -26 | 48.20 | -1,253.20 | -0,1% | |
| 2025-07-01 | Talasaz AmirAli | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -72,068 | 50.67 | -3,651,793.66 | -426,4% | |
| 2025-07-01 | Talasaz AmirAli | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -27,932 | 51.40 | -1,435,836.08 | -167,6% | |
| 2025-06-18 | Tariq Musa | Director | Open Market Sale | -3,213 | 49.47 | -158,947.11 | -18,6% | |
| 2025-06-18 | POTTER MYRTLE S | Director | Open Market Sale | -26 | 49.47 | -1,286.22 | -0,2% | |
| 2025-06-17 | CLARK IAN T | Director | Open Market Sale | -6,672 | 48.38 | -322,818.72 | -37,7% | |
| 2025-06-16 | POTTER MYRTLE S | Director | Open Market Sale | -2,626 | 49.70 | -130,512.20 | -15,2% | |
| 2025-06-13 | Joyce Meghan V. | Director | Open Market Sale | -3,337 | 47.22 | -157,573.14 | -18,4% | |
| 2025-06-09 | Talasaz AmirAli | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -77,853 | 50.09 | -3,899,937.04 | -455,3% | |
| 2025-06-06 | Talasaz AmirAli | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -39,751 | 50.07 | -1,990,420.02 | -232,4% | |
| 2025-06-05 | Talasaz AmirAli | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -1,680 | 50.00 | -84,006.89 | -9,8% | |
| 2025-06-03 | Kalia Kumud | Officer, Chief Information Officer | Open Market Sale | -4,000 | 46.39 | -185,561.60 | -21,7% | |
| 2025-06-02 | Joyce Meghan V. | Director | Open Market Sale | -100 | 41.66 | -4,166.00 | -0,5% | |
| 2025-05-19 | Tariq Musa | Director | Open Market Sale | -116 | 40.04 | -4,644.64 | -0,5% | |
| 2025-05-02 | Talasaz AmirAli | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -13,932 | 50.47 | -703,150.83 | -82,1% | |
| 2025-05-01 | Talasaz AmirAli | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -1,748 | 51.56 | -90,130.73 | -10,5% | |
| 2025-05-01 | Talasaz AmirAli | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -18,069 | 47.67 | -861,275.15 | -100,6% | |
| 2025-05-01 | Talasaz AmirAli | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -38,477 | 48.71 | -1,874,299.32 | -218,8% | |
| 2025-05-01 | Talasaz AmirAli | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -44,691 | 49.53 | -2,213,710.59 | -258,5% | |
| 2025-05-01 | Talasaz AmirAli | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -354 | 52.57 | -18,610.81 | -2,2% | |
| 2025-05-01 | Talasaz AmirAli | Director, Officer, Co-Chief Executive Officer | Open Market Sale | -3,445 | 50.91 | -175,394.60 | -20,5% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.